Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (N-Term) Peptide
APOBEC3G
Reactivity: Human
BP
Sodium azide
Catalog No. ABIN1382177
Quick Overview for Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (N-Term) Peptide (ABIN1382177)
Target
APOBEC3G
(Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
Origin
Human
Application
Blocking Peptide (BP)
-
-
Protein Region
- N-Term
-
Characteristics
-
15 amino acids near the amino terminus of human APOBEC3G.
Human
-
-
Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) peptide
APOBEC3G Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- The peptide is used for blocking the activity of APOBEC3G.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 200 μg/mL
-
Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
Target
-
You are here:
